TECH vs VTR
Bio-Techne Corp (TECH) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the TECH and VTR stock pages for the full models.
Not investment advice.